Getein Biotech, Inc (603387.SS)
CNY 8.59
(-0.12%)
CNY 8.59
(-0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.36 Billion | 1.82 Billion | 1.4 Billion | 1.12 Billion | 968.2 Million | 686.23 Million |
| Cost of Revenue | 446.06 Million | 636.39 Million | 482.46 Million | 415.29 Million | 263.41 Million | 144.76 Million |
| Gross Profit | 923.09 Million | 1.18 Billion | 919.24 Million | 708.03 Million | 704.79 Million | 541.46 Million |
| Operating Expenses | 616.5 Million | 630.41 Million | 482.91 Million | 360.75 Million | 326.63 Million | 289.35 Million |
| Selling, General and Administrative Expenses | 375 Million | 338.17 Million | 263.47 Million | 208.68 Million | 199.11 Million | 172.44 Million |
| Research and Development Expenses | 217.99 Million | 223.22 Million | 163.39 Million | 119.06 Million | 104.73 Million | 80.59 Million |
| Other Expenses | - | 69.01 Million | 56.04 Million | 33 Million | 22.78 Million | 4.47 Million |
| Cost and Expenses | 1.06 Billion | 1.26 Billion | 965.37 Million | 776.05 Million | 590.04 Million | 434.12 Million |
| Operating Income | 306.58 Million | 563.25 Million | 452.78 Million | 377.99 Million | 398.91 Million | 282.79 Million |
| Interest Expense | 17.48 Million | 16.6 Million | 14.31 Million | 6.22 Million | 1.43 Million | 3.77 Million |
| Income Tax Expense | 20.86 Million | 56.03 Million | 39.62 Million | 43.72 Million | 46.02 Million | 36.62 Million |
| Earnings before Tax | 304.94 Million | 559.97 Million | 451.63 Million | 374.04 Million | 395.97 Million | 287.27 Million |
| Net Income | 279.77 Million | 498.9 Million | 398.99 Million | 304.73 Million | 339.67 Million | 249.61 Million |
| Earnings Per Share Basic | 0.55 | 0.98 | 0.79 | 0.60 | 0.67 | 0.49 |
| Earnings Per Share Diluted | 0.55 | 0.98 | 0.79 | 0.60 | 0.66 | 0.49 |
| Weighted Average Shares Outstanding | 508.67 Million | 507.15 Million | 507.8 Million | 509.01 Million | 507.75 Million | 507.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 508.67 Million | 507.15 Million | 507.8 Million | 509.01 Million | 512.12 Million | 509.62 Million |
| Gross Margin | 0.67 | 0.65 | 0.66 | 0.63 | 0.73 | 0.79 |
| EBIT Margin | 0.31 | 0.38 | 0.37 | 0.36 | 0.44 | 0.41 |
| Profit Margin | 0.20 | 0.27 | 0.28 | 0.27 | 0.35 | 0.36 |
| EBITDA | 426.88 Million | 654.55 Million | 522.11 Million | 424.74 Million | 431.43 Million | 276.86 Million |
| Earnings Before Tax Margin | 0.22 | 0.31 | 0.32 | 0.34 | 0.41 | 0.41 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 259.34 Million | 296.08 Million | 321.58 Million | 368.2 Million | 1.36 Billion | 297.6 Million |
| Cost of Revenue | 79.06 Million | 98.15 Million | 91.73 Million | 119.83 Million | 446.06 Million | 101.89 Million |
| Gross Profit | 180.27 Million | 197.92 Million | 229.84 Million | 248.36 Million | 923.09 Million | 195.7 Million |
| Operating Expenses | 130.84 Million | 141.29 Million | 129.58 Million | 177.25 Million | 654.81 Million | 165.04 Million |
| Selling, General and Administrative Expenses | 83.89 Million | 69.97 Million | 88.84 Million | 45.67 Million | - | 151.78 Million |
| Research and Development Expenses | 44.81 Million | 48.41 Million | 44 Million | 57.34 Million | - | 53.36 Million |
| Other Expenses | -2.13 Million | -146.66 Thousand | -377.4 Thousand | -2 Million | -2.22 Million | 519.12 Thousand |
| Cost and Expenses | 209.91 Million | 239.45 Million | 221.31 Million | 297.09 Million | 1.1 Billion | 266.94 Million |
| Operating Income | 49.43 Million | 66.22 Million | 100.43 Million | 56.96 Million | 306.58 Million | 61.32 Million |
| Interest Expense | 4.19 Million | 4.99 Million | 2.91 Million | 2.79 Million | 16.94 Million | 4.77 Million |
| Income Tax Expense | 5.35 Million | 2.64 Million | 12.61 Million | 5.13 Million | 20.86 Million | 279.45 Thousand |
| Earnings before Tax | 63.39 Million | 66.12 Million | 100.05 Million | 55.54 Million | 304.94 Million | 62.36 Million |
| Net Income | 55.47 Million | 60.79 Million | 86.01 Million | 50.7 Million | 279.77 Million | 60.34 Million |
| Earnings Per Share Basic | 0.11 | 0.12 | 0.17 | 0.10 | - | 0.12 |
| Earnings Per Share Diluted | 0.11 | 0.12 | 0.17 | 0.10 | - | 0.12 |
| Weighted Average Shares Outstanding | 507.15 Million | 507.15 Million | 505.96 Million | 507.57 Million | 508.67 Million | 507.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 507.15 Million | 507.15 Million | 505.96 Million | 507.57 Million | 508.67 Million | 507.15 Million |
| Gross Margin | 0.70 | 0.67 | 0.71 | 0.67 | 0.67 | 0.66 |
| EBIT Margin | 0.26 | 0.24 | 0.34 | 0.22 | - | 0.19 |
| Profit Margin | 0.21 | 0.21 | 0.27 | 0.14 | 0.20 | 0.20 |
| EBITDA | 67.58 Million | 71.86 Million | 109.01 Million | 81.46 Million | - | 56.7 Million |
| Earnings Before Tax Margin | 0.19 | 0.22 | 0.31 | 0.15 | 0.22 | 0.21 |
SYRMA
FRS
DIA
BBAR
DIS
TSQ